{
    "2021-07-13": [
        [
            {
                "time": "",
                "original_text": "沪深港通资金医药股流向数据库",
                "features": {
                    "keywords": [
                        "沪深港通",
                        "资金",
                        "医药股",
                        "流向",
                        "数据库"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药暴跌35%，还有救吗？",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "暴跌",
                        "35%"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药现1笔大宗交易 共成交9,972.34万元",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "大宗交易",
                        "9,972.34万元"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "北向资金今日净买入25.8亿元，中兴通讯、山西汾酒净买入额均创新高",
                "features": {
                    "keywords": [
                        "北向资金",
                        "净买入",
                        "25.8亿元",
                        "中兴通讯",
                        "山西汾酒"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "通信",
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "请珍惜4000亿的恒瑞医药",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "4000亿"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "2021年医药生物中期策略报告：需求长期景气 布局创新、医疗服务和消费主线",
                "features": {
                    "keywords": [
                        "医药生物",
                        "中期策略",
                        "需求",
                        "景气",
                        "创新",
                        "医疗服务",
                        "消费"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "孙飘扬再出山：PD-1销售额增长已至尾声，恒瑞医药将迎至暗时刻",
                "features": {
                    "keywords": [
                        "孙飘扬",
                        "PD-1",
                        "恒瑞医药",
                        "销售额",
                        "增长",
                        "至暗时刻"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "创始人复出！半年市值蒸发2000亿的恒瑞医药，股价能止跌吗？",
                "features": {
                    "keywords": [
                        "创始人",
                        "恒瑞医药",
                        "市值",
                        "蒸发",
                        "2000亿",
                        "止跌"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-07-12",
                "original_text": "A股融资融券日报：两融余额增加117.16亿元（7月12日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额",
                        "增加",
                        "117.16亿元"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "暴跌 2000 亿、深陷行贿丑闻，中国最大医药巨头“渡劫”？",
                "features": {
                    "keywords": [
                        "暴跌",
                        "2000亿",
                        "行贿丑闻",
                        "医药巨头",
                        "渡劫"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}